Oral Equivalent to IV Ampicillin/Sulbactam
Amoxicillin-clavulanate (Augmentin) 875/125 mg twice daily is the oral equivalent to intravenous ampicillin/sulbactam. 1
Rationale for This Recommendation
Ampicillin/sulbactam and amoxicillin/clavulanate share nearly identical antimicrobial spectra and mechanisms of action. Both combine a beta-lactam antibiotic (ampicillin or amoxicillin) with a beta-lactamase inhibitor (sulbactam or clavulanic acid) to extend coverage against beta-lactamase-producing organisms.
Key Pharmacologic Similarities
Spectrum of activity: Both combinations cover the same pathogens including beta-lactamase-producing strains of Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis, anaerobes including Bacteroides fragilis, and many Enterobacteriaceae 1, 2
Clinical applications: Guidelines consistently list these agents interchangeably for the same indications, including animal bites, human bites, skin and soft tissue infections, and intra-abdominal infections 1, 3
Guideline Support
The IDSA Skin and Soft Tissue Infections guidelines explicitly recommend:
- Oral therapy: Amoxicillin-clavulanate 875/125 mg twice daily
- IV therapy: Ampicillin-sulbactam 1.5-3 g every 6-8 hours
These are listed as direct equivalents for treating animal and human bites 1.
Important Considerations
Bioavailability Advantage
While there is no direct oral formulation of ampicillin/sulbactam available in the United States 4, sultamicillin (a mutual prodrug of ampicillin and sulbactam) exists in some countries and provides superior oral bioavailability compared to ampicillin alone 5, 6, 7, 8. However, this is not FDA-approved or available in the US.
Dosing Equivalence
- Standard oral dose: Amoxicillin-clavulanate 875/125 mg twice daily
- For more severe infections: May use 875/125 mg three times daily or consider higher doses based on infection severity
- Pediatric dosing: 45 mg/kg/day of amoxicillin component divided twice daily (up to adult dose)
When Oral Transition is Appropriate
Transition from IV ampicillin/sulbactam to oral amoxicillin-clavulanate is appropriate when:
- Patient is clinically improving
- Able to tolerate oral medications
- No evidence of severe sepsis or hemodynamic instability
- Adequate source control has been achieved (if applicable)
Common Pitfall
Do not use oral ampicillin alone as a substitute for IV ampicillin/sulbactam. Ampicillin lacks the beta-lactamase inhibitor component and will be ineffective against beta-lactamase-producing organisms that ampicillin/sulbactam was targeting 9.